|
Volumn , Issue , 2009, Pages 343-345
|
Case presentations on two patients who received bortezomib for antibody mediated rejection at BIDMC.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AUTOANTIBODY;
BORONIC ACID DERIVATIVE;
BORTEZOMIB;
CREATININE;
HLA ANTIGEN;
HLA DQ ANTIGEN;
IMMUNOLOGIC FACTOR;
IMMUNOSUPPRESSIVE AGENT;
MONOCLONAL ANTIBODY;
PROTEINASE INHIBITOR;
PYRAZINE DERIVATIVE;
RITUXIMAB;
ADULT;
ARTICLE;
BLOOD;
CASE REPORT;
CELLULAR IMMUNITY;
CHRONIC KIDNEY FAILURE;
FEMALE;
GENETICS;
GRAFT REJECTION;
HUMAN;
HUMORAL IMMUNITY;
IMMUNOLOGY;
KIDNEY POLYCYSTIC DISEASE;
KIDNEY TRANSPLANTATION;
MALE;
PERITONEAL DIALYSIS;
PLASMAPHERESIS;
RENAL REPLACEMENT THERAPY;
REOPERATION;
TREATMENT FAILURE;
ADULT;
ANTIBODIES, MONOCLONAL;
AUTOANTIBODIES;
BORONIC ACIDS;
CREATININE;
FEMALE;
GRAFT REJECTION;
HLA ANTIGENS;
HLA-DQ ANTIGENS;
HUMANS;
IMMUNITY, CELLULAR;
IMMUNITY, HUMORAL;
IMMUNOLOGIC FACTORS;
IMMUNOSUPPRESSIVE AGENTS;
KIDNEY FAILURE, CHRONIC;
KIDNEY TRANSPLANTATION;
MALE;
PERITONEAL DIALYSIS;
PLASMAPHERESIS;
POLYCYSTIC KIDNEY DISEASES;
PROTEASE INHIBITORS;
PYRAZINES;
RENAL DIALYSIS;
REOPERATION;
TREATMENT FAILURE;
|
EID: 77954617647
PISSN: 08909016
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (5)
|
References (0)
|